A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
Clinical trial NCT03962738 · COMPLETED
Trial details
- NCT number
- NCT03962738
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2020-06-08
- Enrollment
- 846
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.